No-reflow phenomenon and prognosis in patients with acute myocardial infarction

Nature Clinical Practice Cardiovascular Medicine

Volumn 3, Issue 9, 2006, Pages 499-506

  Ito, Hiroshi ^a  

^a Sakurabashi Watanabe Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE; ANTITHROMBOCYTIC AGENT; CARIPORIDE; CLOPIDOGREL; CONTRAST MEDIUM; CORONARY VASODILATING AGENT; ENDOTHELIN A RECEPTOR ANTAGONIST; ENIPORIDE; ERYTHROPOIETIN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; LEUKOCYTE ANTIBODY; MONOCLONAL ANTIBODY; NICARDIPINE; NICORANDIL; NITRATE; NITROPRUSSIDE SODIUM; PAPAVERINE; TECHNETIUM 99M; THALLIUM; TIROFIBAN; VERAPAMIL;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC PROCEDURE; DOPPLER FLOWMETRY; DRUG MECHANISM; ELECTROCARDIOGRAPHY; EMBOLISM; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HIGH RISK POPULATION; HUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ADENOSINE; CLINICAL TRIALS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; HUMANS; MICROCIRCULATION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; THROMBECTOMY; VASODILATOR AGENTS;

EID: 33747874714     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0632     Document Type: Review

References (53)

1. Ito H et al. (1996) Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 93: 223-228
2. Kloner RA et al. (1974) The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54: 1496-1508
3. Kloner RA et al. (1980) Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: Which comes first? Circulation 62: 945-952
4. Komamura K et al. (1994) Progressive decreases in coronary vein flow during reperfusion in acute myocardial infarction: Clinical documentation of the no reflow phenomenon after successful thrombolysis. J Am Coll Cardiol 24: 370-377
5. Manciet LH et al. (1994) Microvascular compression during myocardial ischemia: Mechanistic basis for no-reflow phenomenon. Am J Physiol 266: H1541-H1550
6. Topol EJ et al. (2000) Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101: 570-580
7. Fuster V et al. (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 326: 242-250
8. Iwakura K et al. (2001) Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 38: 472-477
9. Coggins MP et al. (2001) Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow. Circulation 104: 2471-2477
10. Iwakura K et al. (2003) Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41: 1-7
11. Malmberg K et al. (1999) Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99: 2626-2632
12. Tanaka A et al. (2002) No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 105: 2148-2152
13. Kotani J et al. (2002) Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 106: 1672-1677
14. Hori M et al. (1986) Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol 250: H509-H518
15. Okamura A et al. (2005) Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: Efficacy of distal protection device. J Am Coll Cardiol 45: 212-215
16. Ito H et al. (1992) Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 85: 1699-1705
17. Villanueva FS et al. (1993) Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implication in determining extent of myocardial salvage. Circulation 88: 2596-2606
18. Yano A et al. (2004) Myocardial contrast echocardiography with a new calibration method can estimate myocardial viability in patients with myocardial infarction. J Am Coll Cardiol 43: 1799-1806
19. Zijlstra F et al. (1993) A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 328: 680-684
20. Simes RJ et al. (1995) Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation 91: 1923-1928
21. Ito H et al. (1996) Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 93: 1993-1999
22. Grines CL et al. (1999) Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 341: 1949-1956
23. Gibson CM et al. (2000) Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101: 125-130
24. Iwakura K et al. (1996) Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation 94: 1269-1275
25. Akasaka T et al. (2000) Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting. Circulation 101: 2361-2367
26. Yamamoto K et al. (2002) Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: Insight into mechanisms of microvascular dysfunction. J Am Coll Cardiol 40: 1755-1760
27. Wehrens X et al. (2000) A comparison of electrocardiographic changes during reperfusion of acute myocardial infarction by thrombolysis or percutaneous transluminal coronary angioplasty. Am Heart J 139: 430-436
28. Claeys MJ et al. (1999) Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: Importance of microvascular reperfusion injury on clinical outcome. Circulation 99: 1972-1977
29. Wu KC et al. (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97: 765-772
30. Taylor AJ et al. (2004) Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation 109: 2080-2085
31. Ito H et al (1996) Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 93: 223-228
32. Morishima I et al. (2000) Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36: 1202-1209
33. Kocher AA (2001) Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436
34. Kunichika H et al. (2004) Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study. J Am Coll Cardiol 43: 276-283
35. Montalescot G et al. (2001) Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344: 1895-1903
36. Stone GW et al. (2005) Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: A randomized controlled trial. JAMA 293: 1063-1072
37. Gick M et al. (2005) Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 112: 1462-1469
38. Mizote I et al. (2005) Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardial infarction who had angioscopically defined ruptured plaque. Circulation 112: 1001-1007
39. Makaryus AN et al. (2006) Efficacy of rheolytic thrombectomy in early versus late myocardial infarction. J Interv Cardiol 19: 135-140
40. Ali A (2004) Rheolytic thrombectomy in patients with acute MI did not result in a reduction in myocardial infarct size. Presented at Transcatheter Cardiovascular Therapeutics: 2004 September 27 to October 1; Washington, DC
41. Tsang A et al. (2004) Postconditioning: A form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 95: 230-232
42. Staat P et al. (2005) Postconditioning the human heart. Circulation 112: 2143-2148
43. Marzilli M et al. (2000) Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 101: 2154-2159
44. Ross AM et al. (2005) A randomized, double-blinded, placebo-controlled multicentertrial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45: 1775-1780
45. Ito H et al. (1999) Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 33: 654-660
46. Ishii H et al. (2005) Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 112: 1284-1288
47. Taniyama Y (1997) Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 30: 1193-1199
48. Umemura S (2006) The effect of verapamil on the restoration of myocardial perfusion and functional recovery in patients with angiographic no-reflow after primary percutaneous coronary intervention. Nucl Med Commun 27: 247-254
49. Pasceri V (2005) Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol 95: 1358-1361
50. Theroux P (2000) Myocardial cell protection: A challenging time for action and a challenging time for clinical research. Circulation 101: 2874-2876
51. Theroux P et al. (2000) Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation 102: 3032-3038
52. + exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol 38: 1644-1650
53. Cai Z and Semenza GL (2004) Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/ reperfusion injury. Circulation 109: 2050-2053